UC Davis Health vascular surgeons are among the first in the country to treat patients with thoracic aortic disease by using ...
StockStory.org on MSN15h
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the BunchWrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, ...
Featuring a simply intelligence interface and substantial technological upgrades, the new multiplatform presents a new era in ...
Beijing's Changping district has set up a fund cluster with a total value of 15 billion yuan (US$2.1 billion), aiming to support the transformation of scientific and technological achievements, ...
At 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively.At 12 ...
Extravascular solutions allow physicians to deliver critical therapy while maintaining the integrity of the heart, commented ...
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders ...
The COVID pandemic could be a cause, but perhaps not the only reason, for the changes from 2018 to 2022. Only time will tell.
Cord Blood Platelet-Rich Plasma potentially promotes wound healing following cesarean section: Study
Cesarean section, a surgical procedure for delivering a baby through an incision made in the mother’s abdomen, is generally ...
Intech Investment Management LLC raised its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 77.5% in the ...
11h
Zacks Investment Research on MSNABT Stock to Gain From FDA IDE Approval for Its Coronary IVL SystemAbbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from the CLEAR study were presented at the 40th Annual European Association of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results